Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial

AM Wills, J Hubbard, EA Macklin, J Glass, R Tandan… - The Lancet, 2014 - thelancet.com
Background Amyotrophic lateral sclerosis is a fatal neurodegenerative disease with few
therapeutic options. Mild obesity is associated with greater survival in patients with the …

Complementary and alternative therapies in amyotrophic lateral sclerosis

RS Bedlack, N Joyce, GT Carter… - Neurologic …, 2015 - neurologic.theclinics.com
Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis - Neurologic Clinics
Skip to Main Content Skip to Main Menu Advertisement Neurologic Clinics Log in Register Log …

Systematic review of the prognostic role of body mass index in amyotrophic lateral sclerosis

P Ning, B Yang, S Li, X Mu, Q Shen, F Hu… - … Lateral Sclerosis and …, 2019 - Taylor & Francis
Studies have suggested that obesity is associated with better prognosis among individuals
with various types of neurodegenerative diseases, and while some studies suggest that the …

[HTML][HTML] Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis

EJ Kasarskis, MS Mendiondo, DE Matthews… - The American journal of …, 2014 - Elsevier
Background: Patients with amyotrophic lateral sclerosis (ALS) experience progressive limb
weakness, muscle atrophy, and dysphagia, making them vulnerable to insufficient energy …

Hypermetabolism is a reality in amyotrophic lateral sclerosis compared to healthy subjects

P Fayemendy, B Marin, A Labrunie, Y Boirie… - Journal of the …, 2021 - Elsevier
Abstract Rationale Hypermetabolism (HM) in Amyotrophic lateral sclerosis (ALS) is the
reflection of a high energy metabolic level, but this alteration seems controversial. The main …

[HTML][HTML] Body composition in amyotrophic lateral sclerosis subjects and its effect on disease progression and survival

R Tandan, EA Levy, DB Howard, J Hiser… - The American journal of …, 2022 - Elsevier
Background Motor neuron degeneration and malnutrition alter body composition in
amyotrophic lateral sclerosis (ALS). Resulting losses of weight, fat mass (FM), and fat-free …

Patient-reported problematic symptoms in an ALS treatment trial

D Raheja, HE Stephens, E Lehman… - … Lateral Sclerosis and …, 2016 - Taylor & Francis
This study was undertaken to determine which symptoms are perceived to be most
problematic for patients with ALS and how their severity changes over time. A retrospective …

Pulmonary function decline in amyotrophic lateral sclerosis

TD Heiman-Patterson, O Khazaal, D Yu… - … Lateral Sclerosis and …, 2021 - Taylor & Francis
Background: There has been no comprehensive longitudinal study of pulmonary functions
(PFTS) in ALS determining which measure is most sensitive to declines in respiratory …

Factors associated with Noninvasive ventilation compliance in patients with ALS/MND

CE Jackson, TD Heiman-Patterson… - … lateral sclerosis and …, 2021 - Taylor & Francis
Background: Although noninvasive ventilation (NIV) improves survival and quality of life
(QOL) in ALS, use of NIV is suboptimal. Objective: To determine compliance with “early” NIV …

[HTML][HTML] Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis

R Meanti, E Bresciani, L Rizzi, S Coco… - Current …, 2023 - ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS) arises from neuronal death due to complex interactions
of genetic, molecular, and environmental factors. Currently, only two drugs, riluzole and …